Jupiter Life Line Hospitals Ltd. · NSE:JLHL

Jupiter Life Line Hospitals — Q1 FY2026 Earnings Presentation

10 slides from Jupiter Life Line Hospitals's earnings presentation, Aug 1, 2025

  1. Slide 1: Exchange filing cover letter for investor presentation

    August 01, 2025 To, To, National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, P. J. Towers, Bandra-Kurla Complex, 25th Floor, Dalal Street, Fort Bandra (East), Mumbai-400 051 Mumbai 400 001 Symbol: JLHL Code: 543980 Subject: Investor Presentation for the quarter ended June 30, 2025 Refer

  2. Slide 2: Jupiter Life Line Hospitals Limited Results Presentation - Q1FY26

    Jupiter Life Line Hospitals Limited Results Presentation - Q1FY26 1

  3. Slide 3: Safe Harbour

    Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Jupiter Life Line Hospitals Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe

  4. Slide 4: Management Commentary

    Management Commentary Dr. Ankit Thakker JMD & CEO “We are pleased to report a strong performance in Q1FY26, with Total Income of Rs 347.6 crore along with an EBITDA of Rs 78.1 cr, supported by improved occupancy levels across all units. Our new projects are progressing as per plan, with Dombivli exp

  5. Slide 5: Key Performance Highlights of Q1FY26

    Key Performance Highlights of Q1FY26 Total Income EBITDA PAT Rs 347.6 cr Rs 78.1 cr Rs 43.9 cr 20.5 % YoY 19.6 % YoY 1.6 % YoY IPD and OPD revenue grew by Overall patient volumes Depreciation has increased by 19.6% and 15.5% YoY increased by 11.7% YoY, Rs 10.2 cr primarily due to respectively, indic

  6. Slide 6: Q1FY26 Performance Highlights

    Q1FY26 Performance Highlights Rs in Cr Total Income EBITDA PBT PAT -1.6% +20.5% +19.6% +2.3% 44.6 43.9 347.6 78.1 60.1 61.5 288.6 65.3 274.8 229.9 54.6 63.1 6.6 4.1 3.1 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 IPD Sale of Pharmacy Products* OPD Others 5 *Jupiter Pharmacy was incorpora

  7. Slide 7: Q1FY26 Operating Metrics

    Q1FY26 Operating Metrics Operational Bed Capacity(1) Average Occupancy Rate(2) IPD & OPD Volumes (‘000)(3) Census Beds Non - Census Beds 1,061 63.9% 259.1 961 60.1% 231.9 13.3 IPD 12.7 829 929 OPD 219.2 245.8 132 132 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY25 Q1FY26 ARPOB(4) ALOS (in Days)(5) Payor Mix Gove

  8. Slide 8: Consolidated Profit & Loss Statement

    Consolidated Profit & Loss Statement Profit and Loss (in Rs. cr) Q1FY26 Q1FY25 YoY Q4FY25 QoQ FY25 Revenue from Operations 344.5* 284.5 21.1% 323.1 6.6% 1,245.4 Other Income - Operational 3.1 4.1 3.6 16.1 Total Income 347.6 288.6 20.5% 326.7 6.4% 1,261.5 Cost of Goods Sold 68.3 50.2 61.1 230.1 Gross

  9. Slide 9: Scaling up for better care: Setting up New hospitals

    Scaling up for better care: Setting up New hospitals Expected Bed Capex Expected Bed Total Bed Expected to Location Addition Phase Estimated Current Status of Phase I Addition Phase I Capacity Operationalise II (Rs in cr) Dombivli 200-220 280-300 500 500 Q1FY27 Construction is on track Pune II 200-2

  10. Slide 10: Thank You

    http://www.sgapl.net/images/sgapl_logo.jpg Jupiter JupiterLife LifeLine LineHospitals HospitalsLimited Limited Strategic Growth Advisors Pvt. Ltd. CIN: CIN:L85100MH2002PLC137908 L85100MH2002PLC137908 CIN: U74140MH2010PTC204285 Mandar Chavan / Rahul Agarwal investor.relations@jupiterhospital.com inve

Jupiter Life Line Hospitals — Q1 FY2026 Earnings Presentation on 6ix